Gene · 7917
BAG6: BAG cochaperone 6
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. BAG6: BAG cochaperone 6. Genes, record 7917. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/7917
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P46379 | Large proline-rich protein BAG6 | 1,132 | 10 | Ensembl, GeneID, HGNC |
Source UniProt
Patents44
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 38706 | P46379 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 38708 | P46379 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 38830 | P46379 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 38836 | P46379 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 9716 | P46379 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 9970 | P46379 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 14720 | P46379 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 9970 | P46379 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 9716 | P46379 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 8583 | P46379 | Espacenet |
1 to 10 of 44
See all 44 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,313
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | BAG6 papers | Newest fiscal year |
|---|---|---|---|
| ZIADK033008 | Mechanism of protein quality control at the endoplasmic reticulum | 9 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 7 | 2025 |
| P30CA023108 | Cancer Center Support Grant | 7 | 2025 |
| P01AI039671 | Costimulatory Mechanisms of Autoimmunity | 6 | 2025 |
| R01AG011085 | Ubiquitin‐mediated proteolysis and cell cycle control | 5 | 2025 |
| P30CA022453 | CANCER CENTER SUPPORT GRANT | 4 | 2025 |
| P30CA016359 | Cancer Center Support Grant | 3 | 2025 |
| P30CA046934 | University of Colorado Cancer Center Support Grant | 3 | 2025 |
| P30CA076292 | Moffitt Cancer Center Support Grant | 3 | 2025 |
| P30DK063491 | Diabetes Research Center (DRC) | 3 | 2025 |
1 to 10 of 1,313Source NIH's project files
See all 1,313 nih grantsPapers1,423
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| BAG6-RNF115 Couples Protein Quality Control with Ribosome Assembly. | bioRxiv | 2026 | 42620044 | PubTator, text mining | PubMed |
| RNF126 in Physiology and Disease: A Multifunctional RING-Type E3 Ubiquitin Ligase in Protein Homeostasis, DNA Repair, and Cancer. | Cells | 2026 | 42439634 | PubTator, text mining | PubMed |
| Identification and diagnostic potential of pyroptosis-related genes in endometriosis: A novel bioinformatics analysis and validation. | PLoS One | 2026 | 42263089 | PubTator, text mining | PubMed |
| TIM-3 in AML: pathogenic roles and therapeutic targetability. | Clin Exp Med | 2026 | 41925920 | PubTator, text mining | PubMed |
| Mechanisms of tumor cell evasion from NK cell-mediated killing and advances in NK cell-based cancer immunotherapy. | Pharm Sci Adv | 2026 | 41799416 | PubTator, text mining | PubMed |
| Immune Exhaustion in Chronic Infection and Cancer: Signaling Pathways and Therapeutic Interventions. | MedComm (2020) | 2026 | 41768369 | PubTator, text mining | PubMed |
| Proteasomal control of transcription factors: mechanisms, regulation and dysregulation. | Cell Mol Life Sci | 2026 | 41764121 | PubTator, text mining | PubMed |
| Microautophagy: current understanding of its molecular mechanisms and functions. | Autophagy Rep | 2026 | 41756808 | PubTator, text mining | PubMed |
| Phosphoproteomic Profiling of Multiple Myeloma Based on Ex Vivo Drug Sensitivity Resistance Testing Identifies Phosphorylation Signatures Associated with Drug Response. | Biomolecules | 2026 | 41750391 | PubTator, text mining | PubMed |
| Exosomal bioactive molecules: molecular regulation, functional heterogeneity, and translational implications in disease diagnostics and therapeutics. | Clin Exp Med | 2026 | 41748937 | PubTator, text mining | PubMed |
1 to 10 of 1,423
See all 1,423 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/7917
GET https://conductscience.org/api/genes/v1/7917/patents?page=2